Search Result

Results for "

concentration-dependent

" in MedChemExpress (MCE) Product Catalog:

By Targets:	5-HT Receptor (5) Adrenergic Receptor (4) Antibiotic (2) Apoptosis (5) Aryl Hydrocarbon Receptor (1) Autophagy (2) Bacterial (1) BCRP (1) Biochemical Assay Reagents (2) Calcium Channel (3) COX (2) Cytochrome P450 (4) DNA Alkylator/Crosslinker (1) Dopamine β-hydroxylase (3) Drug Metabolite (1) Endogenous Metabolite (1) Endothelin Receptor (2) Estrogen Receptor/ERR (1) Fat Mass and Obesity-associated Protein (FTO) (1) Fluorescent Dye (1) GABA Receptor (2) Glucosidase (1) GLUT (1) Guanylate Cyclase (1) HDAC (1) Histamine Receptor (1) Histone Methyltransferase (1) Influenza Virus (2) Isotope-Labeled Compounds (1) Leukotriene Receptor (1) Liposome (1) mAChR (2) MEK (1) mGluR (2) Microtubule/Tubulin (2) MNK (1) Motilin Receptor (1) Neuropeptide Y Receptor (1) NF-κB (1) NO Synthase (1) Nuclear Factor of activated T Cells (NFAT) (1) Opioid Receptor (1) P-glycoprotein (1) PAK (1) Phosphodiesterase (PDE) (1) PKC (1) Potassium Channel (10) Prostaglandin Receptor (1) PROTACs (1) RANKL/RANK (1) Ras (1) Reactive Oxygen Species (1) ROS Kinase (1) Sodium Channel (1) STAT (1) TNF Receptor (1) Trk Receptor (1) TRP Channel (1) Tyrosinase (1) VEGFR (1) β-catenin (1)
By Research Areas:	Cancer (24) Cardiovascular Disease (21) Endocrinology (5) Infection (1) Inflammation/Immunology (10) Metabolic Disease (7) Neurological Disease (16)

By Targets:

5-HT Receptor (5)

Adrenergic Receptor (4)

Antibiotic (2)

Apoptosis (5)

Aryl Hydrocarbon Receptor (1)

Autophagy (2)

Bacterial (1)

BCRP (1)

Biochemical Assay Reagents (2)

Calcium Channel (3)

COX (2)

Cytochrome P450 (4)

DNA Alkylator/Crosslinker (1)

Dopamine β-hydroxylase (3)

Drug Metabolite (1)

Endogenous Metabolite (1)

Endothelin Receptor (2)

Estrogen Receptor/ERR (1)

Fat Mass and Obesity-associated Protein (FTO) (1)

Fluorescent Dye (1)

GABA Receptor (2)

Glucosidase (1)

GLUT (1)

Guanylate Cyclase (1)

HDAC (1)

Histamine Receptor (1)

Histone Methyltransferase (1)

Influenza Virus (2)

Isotope-Labeled Compounds (1)

Leukotriene Receptor (1)

Liposome (1)

mAChR (2)

MEK (1)

mGluR (2)

Microtubule/Tubulin (2)

MNK (1)

Motilin Receptor (1)

Neuropeptide Y Receptor (1)

NF-κB (1)

NO Synthase (1)

Nuclear Factor of activated T Cells (NFAT) (1)

Opioid Receptor (1)

P-glycoprotein (1)

PAK (1)

Phosphodiesterase (PDE) (1)

PKC (1)

Potassium Channel (10)

Prostaglandin Receptor (1)

PROTACs (1)

RANKL/RANK (1)

Ras (1)

Reactive Oxygen Species (1)

ROS Kinase (1)

Sodium Channel (1)

STAT (1)

TNF Receptor (1)

Trk Receptor (1)

TRP Channel (1)

Tyrosinase (1)

VEGFR (1)

β-catenin (1)

By Research Areas:

Cancer (24)

Cardiovascular Disease (21)

Endocrinology (5)

Infection (1)

Inflammation/Immunology (10)

Metabolic Disease (7)

Neurological Disease (16)

Inhibitors & Agonists

Fluorescent Dye

Biochemical Assay Reagents

Peptides

Natural
Products

Isotope-Labeled Compounds

Targets Recommended: Apical Sodium-Dependent Bile Acid Transporter CaMK CDK SNIPERs DNA-PK VDAC SGLT PDK-1

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-B2179

Cloperastine fendizoate	Potassium Channel	Inflammation/Immunology
Cloperastine fendizoate inhibits the hERG K ⁺ currents in a concentration-dependent manner with an IC₅₀ value of 27 nM.

HY-B2133

Cloperastine hydrochloride

Cloperastine hydrochloride inhibits the hERG K ⁺ currents in a concentration-dependent manner with an IC₅₀ value of 27 nM .

Cloperastine hydrochloride
Cloperastine hydrochloride inhibits the hERG K ⁺ currents in a concentration-dependent manner with an IC₅₀ value of 27 nM .

HY-U00027

Quinotolast sodium FR71021	Histamine Receptor Leukotriene Receptor Prostaglandin Receptor	Inflammation/Immunology Endocrinology
Quinotolast sodium in the concentration range of 1-100 μg/mL inhibits histamine, LTC₄ and PGD₂ release in a concentration-dependent manner.

HY-131871

Ethyl LipotF	Fat Mass and Obesity-associated Protein (FTO)	Cancer
Ethyl LipotF is a selective FTO inhibitor that significant increases modified N6-methyladenosine (m6A) levels in HeLa cells in a concentration-dependent manner .

HY-N5035

Moscatin

Plicatol B
Others Cardiovascular Disease

Moscatin inhibits AA-induced platelet aggregation in a concentration-dependent manner with IC₅₀ values 37.2 μM .

Moscatin Plicatol B	Others	Cardiovascular Disease
Moscatin inhibits AA-induced platelet aggregation in a concentration-dependent manner with IC₅₀ values 37.2 μM .

HY-100407

JNJ16259685 1 Publications Verification	mGluR	Neurological Disease
JNJ16259685 is a selective antagonist of mGlu1 receptor, and inhibits the synaptic activation of mGlu1 in a concentration-dependent manner with IC₅₀ of 19 nM.

HY-19583

Cicaprost

ZK 96480

Cicaprost (ZK 96480) is a prostacyclin receptor (IP) agonist. Cicaprost causes a concentration-dependent relaxation of the artery with an EC₅₀ of 5.8 nM 。

Cicaprost ZK 96480
Cicaprost (ZK 96480) is a prostacyclin receptor (IP) agonist. Cicaprost causes a concentration-dependent relaxation of the artery with an EC₅₀ of 5.8 nM 。

HY-19354

Aglafoline 1 Publications Verification Aglafolin; Rocaglamide U; (-)-Methyl rocaglate	Others	Cardiovascular Disease
Aglafoline inhibits in a selective and concentration-dependent manner the aggregation and ATP release reaction induced in washed rabbit platelets by PAF (platelet-activating factor).

HY-N2929

β-Hydroxypropiovanillone	Glucosidase	Cardiovascular Disease
β-Hydroxypropiovanillone, a natural compound, shows significant concentration-dependent inhibitory effects on α-glucosidase with an IC₅₀ of 257.8 μg/mL .

HY-N7483

1-Dehydroxybaccatin IV	Others	Metabolic Disease
1-Dehydroxybaccatin IV is a taxane diterpene. 1-Dehydroxybaccatin IV shows concentration-dependent NO inhibition, with an IC₅₀ of 32.2 μM .

HY-121026

DMNQ 4 Publications Verification	Reactive Oxygen Species ROS Kinase	Cardiovascular Disease
DMNQ is a redox cycling agent. DMNQ produces hydrogen peroxide in cells in a concentration-dependent manner. DMNQ can induce the increase of ROS production .

HY-109066

Olinciguat IW-1701	Guanylate Cyclase	Cardiovascular Disease
Olinciguat (IW-1701) is an oral guanylate cyclase (sGC) stimulator with concentration-dependent stimulation of sGC in purified rat and human enzyme assays and a whole cell assay .

HY-N12737

15-epi-Danshenol A	Others	Inflammation/Immunology
15-epi-Danshenol A is a diterpenoid with an immune-modulating activity. 15-epi-Danshenol A shows inhibitory effect on B lymphoblasts cells in a concentration-dependent manner .

HY-N10117

2,3-Bis(3-indolylmethyl)indole	RANKL/RANK	Others
2,3-Bis(3-indolylmethyl)indole significantly suppresses RANKL-induced osteoclast formation, actin ring formation, and bone resorption in a concentration-dependent manner.

HY-10562

Ketanserin Maximum Cited Publications 10 Publications Verification R41468	5-HT Receptor Potassium Channel Autophagy	Neurological Disease
Ketanserin is a selective 5-HT2 receptor antagonist. Ketanserin also blocks hERG current (I_hERG) in a concentration-dependent manner (IC₅₀=0.11 μM).

HY-B0267AS

Oxybutynin-d11 chloride	Isotope-Labeled Compounds mAChR Potassium Channel	Neurological Disease
Oxybutynin-d₁₁ (chloride) is the deuterium labeled Oxybutynin chloride. Oxybutynin chloride is an anticholinergic agent, which inhibits vascular Kv channels in a concentration-dependent manner, with an IC50 of 11.51 μM[1].

HY-14304

Zinterol MJ 9184	Adrenergic Receptor	Cardiovascular Disease
Zinterol (MJ 9184) is a potent and selective β2-adrenoceptor agonist . Zinterol increases I_Ca in a concentration-dependent manner with an EC₅₀ of 2.2 nM .

HY-N1210

Spiramine A Spiramine C acetate (ester)	Others	Cancer
Spiramine A (Spiramine C acetate (ester)) is a diterpene alkaloid with antitumor and antimicrobial activity. Spiramine A inhibits PAF-induced rabbit platelet aggregation in a concentration-dependent manner, with an IC₅₀ vallue of 6.7 μM .

HY-N4053

Heraclenin	Nuclear Factor of activated T Cells (NFAT)	Inflammation/Immunology
Heraclenin, a natural furanocoumarin, significantly inhibits T cell receptor-mediated proliferation in human primary T cells in a concentration-dependent manner by targeting nuclear factor of activated T-cells (NFAT) .

HY-P1236

Atrial Natriuretic Peptide (ANP) (1-28), rat Atrial natriuretic factor (1-28) (rat)	Endothelin Receptor	Cardiovascular Disease Endocrinology
Atrial Natriuretic Peptide (ANP) (1-28), rat is a major circulating form of ANP in rats, potently inhibits Angiotensin II (Ang II)-stimulated endothelin-1 secretion in a concentration-dependent manner.

HY-14276

Gallopamil Methoxyverapamil	Calcium Channel	Cardiovascular Disease
Gallopamil (Methoxyverapamil), a methoxy derivative of Verapamil, is a phenylalkylamine calcium antagonist . Gallopamil inhibits acid secretion in a concentration-dependent manner with an IC₅₀ of 10.9 μM . Gallopamil is a potent antiarrhythmic and vasodilator agent .

HY-14276A

Gallopamil hydrochloride Methoxyverapamil hydrochloride	Calcium Channel	Cardiovascular Disease
Gallopamil hydrochloride (Methoxyverapamil hydrochloride), a methoxy derivative of Verapamil, is a phenylalkylamine calcium antagonist . Gallopamil hydrochloride inhibits acid secretion in a concentration-dependent manner with an IC₅₀ of 10.9 μM . Gallopamil hydrochloride is a potent antiarrhythmic and vasodilator agent .

HY-119124

Edoxaban M4 D21-2393	Drug Metabolite	Metabolic Disease
Edoxaban M4, an active metabolite of Edoxaban, shows reproducible, but concentration-dependent matrix effects. Edoxaban (DU-176) is a selective, potent and orally active factor Xa (FXa) inhibitor .

HY-U00201

KRN4884	Potassium Channel	Cardiovascular Disease
KRN4884 is a K ⁺ channel opener. In the presence of intracellular ATP (1 mM), KRN4884 (0.1-3 μM) activates K_ATP channels in a concentration-dependent manner (EC₅₀=0.55 μM).

HY-P1236A

Atrial Natriuretic Peptide (ANP) (1-28), rat TFA Atrial natriuretic factor (1-28) (rat) TFA	Endothelin Receptor	Cardiovascular Disease Endocrinology
Atrial Natriuretic Peptide (ANP) (1-28), rat (TFA) is a major circulating form of ANP in rats, potently inhibits Angiotensin II (Ang II)-stimulated endothelin-1 secretion in a concentration-dependent manner.

HY-10562A

Ketanserin tartrate Maximum Cited Publications 10 Publications Verification R41468 tartrate	5-HT Receptor Potassium Channel Autophagy	Neurological Disease
Ketanserin (R41468) tartrate is a selective 5-HT2 receptor antagonist. Ketanserin tartrate also blocks hERG current (I_hERG) in a concentration-dependent manner (IC₅₀=0.11 μM).

HY-101436

Sematilide CK-1752
Sematilide (CK-1752) is a selective I_Kr channel blocker. Sematilide causes a concentration-dependent inhibition of the delayed rectifier K ⁺ current (IC₅₀=25 μM). Sematilide is a class III antiarrhythmic agent .

HY-101436A

Sematilide hydrochloride CK-1752 hydrochloride
Sematilide hydrochloride (CK-1752 hydrochloride) is a selective I_Kr channel blocker. Sematilide causes a concentration-dependent inhibition of the delayed rectifier K ⁺ current (IC₅₀=25 μM). Sematilide is a class III antiarrhythmic agent .

HY-121710

MonoHER 7-Monohydroxyethylrutoside	Others	Cardiovascular Disease
MonoHER (7-Monohydroxyethylrutoside) is a Carbonyl reductase 1 (CBR1) inhibitor and can be used as a cardioprotective agent. MonoHER inhibits the activity of CBR1 V88 and CBR1 I88 in a concentration-dependent manner .

HY-18719

Endoxifen (Z-isomer) 3 Publications Verification	Estrogen Receptor/ERR Potassium Channel	Cancer
Endoxifen Z-isomer is the most important Tamoxifen metabolite, inducing an anti-estrogenic effect in breast cancer cells expressing ERα. Endoxifen Z-isomer inhibits hERG. This effect is concentration-dependent, with an IC50 value of 1.6 μM.

HY-N9506

Anisatin	GABA Receptor	Neurological Disease
Anisatin, a pure toxic substance isolated from the seeds of a Japanese plant (Illicium anisatum) acts as a picrotoxin-like, non-competitive GABA antagonist. Anisatin suppresses GABA-induced currents in a concentration-dependent manner with an EC₅₀ of ~1.10 μM .

HY-110180

VU0409106	mGluR	Neurological Disease
VU0409106 is a potent and selective mGlu₅ negative allosteric modulator (NAM) with an IC₅₀ of 24 nM. VU0409106 shows anxiolytic effects in rat models in a concentration-dependent manner. VU0409106 also penetrates the blood-brain barrier (BBB) .

HY-N3464

Isopedicin	Phosphodiesterase (PDE)	Metabolic Disease
Isopedicin potently and concentration-dependently inhibits superoxide anion (O2 U?) production in formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP)-activated cells. Isopedicin increases cAMP formation and PKA activity in FMLP-activated cells by inhibiting phosphodiesterase (PDE) activity .

HY-156398

Anti-inflammatory agent 60	NO Synthase β-catenin NF-κB	Inflammation/Immunology
Anti-inflammatory agent 60(compound 21) inhibitsnitric oxide production, with anIC₅₀value of 12.95 μM.Anti-inflammatory agent 60reducesiNOS,phosphorylated p65, andβ-cateninexpression in a concentration-dependent manner .

HY-14304A

Zinterol hydrochloride 1 Publications Verification MJ 9184 hydrochloride	Adrenergic Receptor	Cardiovascular Disease
Zinterol hydrochloride (MJ 9184 hydrochloride) is a potent and selective β2-adrenoceptor agonist . Zinterol hydrochloride increases I_Ca in a concentration-dependent manner with an EC₅₀ of 2.2 nM . Zinterol hydrochloride induces ventricular arrhythmias in conscious heart failure rabbits .

HY-N8475

6-Deoxyisojacareubin	PKC	Cancer
6-Deoxyisojacareubin is a PKC inhibitor that inhibits the proliferation of QGY-7703 cells in a concentration-dependent manner. 6-Deoxyisojacareubin is also a natural product that can be obtained from Garcinia nervosa. 6-Deoxyisojacareubin can be used in cancer research .

HY-N6679

(R)-10,11-Dehydrocurvularin	Antibiotic	Cancer
(R)-10,11-Dehydrocurvularin is a secondary metabolite isolated from Curvularia sp.. (R)-10,11-Dehydrocurvularin displays concentration-dependent cytotoxicity towards human tumor cell lines with a mean IC₅₀ value of 1.25 µM .

HY-101303

5-MCA-NAT
5-MCA-NAT is a melatonin agonist that may target the melatoninMT3 receptor. 5-MCA-NAT can contract the colonic band in a concentration-dependent manner and reduce intraocular pressure (IOP) in glaucomatous monkey eyes, inhibiting the increase in IOP .

HY-113269

alpha-CEHC	Others	Others
alpha-CEHC is a water-soluble metabolite of alpha-tocopherol (α-TOH) with potential antioxidant activity. alpha-CEHC slightly inhibits macrophage-induced low-density lipoprotein (LDL) oxidation, and its inhibitory potency is concentration-dependent .

HY-B0267

Oxybutynin	mAChR Potassium Channel	Neurological Disease
Oxybutynin is an anticholinergic agent, which inhibits vascular K_v channels in a concentration-dependent manner, with an IC₅₀ of 11.51 μM . Oxybutynin is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

HY-10174

PD184161 1 Publications Verification	MEK Apoptosis	Neurological Disease Cancer
PD184161 is an orally active MEK inhibitor. PD184161 inhibits MEK activity (IC₅₀=10-100 nM) in a time- and concentration-dependent manner. PD184161 inhibits cell proliferation and induces apoptosis. PD184161 produces depressive-like behavior .

HY-126967

1-Palmitoyl lysophosphatidic acid	Endogenous Metabolite	Metabolic Disease
1-Palmitoyl lysophosphatidic acid is a lysophosphatidic acid that causes concentration-dependent aggregation of human platelets. 1-Palmitoyl lysophosphatidic acid causes changes in platelet shape, pseudopod development, and particle concentration. 1-Palmitoyl lysophosphatidic acid may induce platelet aggregation by stimulating the release of intracellular Ca .

HY-D1876

ZY-2	Fluorescent Dye	Cancer
ZY-2 is a specific fluorescent probe for pyruvate kinase M2 (PKM2). ZY-2 can image in PKM2-positive cells in a time- and concentration-dependent manner. ZY-2 can be used for the detection of cancer cells .

HY-146711

Tubulin inhibitor 24	Microtubule/Tubulin	Cancer
Tubulin inhibitor 24 is a potent tubulin inhibitor. Tubulin inhibitor 24 inhibits tubulin polymerization. Tubulin inhibitor 24 induces cell cycle arrest at the G2/M phase in a concentration-dependent manner. Tubulin inhibitor 24 shows antitumor activity with no obvious toxicity .

HY-146735

MNK1/2-IN-6	MNK Apoptosis	Cancer
MNK1/2-IN-6 is a potent and selective MNK1/2 inhibitor with IC₅₀s of 2.3 nM and 3.4 nM for MNK1 and MNK2, respectively. MNK1/2-IN-6 induces apoptosis in a concentration-dependent manner .

HY-106323

[Leu13]-Motilin KW-5139	Motilin Receptor	Metabolic Disease
[Leu13]-Motilin (KW-5139) is a motilin analogue. [Leu13]-Motilin stimulates gastrointestinal motility in the rabbit. [Leu13]-Motilin causes concentration-dependent contractions of the gastric antrum, duodenum, jejunum, ileum and the descending colon in vitro .

HY-13289A

Nepicastat hydrochloride 2 Publications Verification SYN-117 hydrochloride; RS-25560-197 hydrochloride	Dopamine β-hydroxylase	Cardiovascular Disease
Nepicastat hydrochloride (SYN-117 hydrochloride) is a selective, potent, and orally active inhibitor of dopamine-beta-hydroxylase. Nepicastat hydrochloride produces concentration-dependent inhibition of bovine (IC₅₀=8.5 nM) and human (IC₅₀=9 nM) dopamine-beta-hydroxylase. Nepicastat hydrochloride can cross the blood-brain barrier (BBB) .

HY-13103

NS 11021 1 Publications Verification
NS 11021 is a potent and specific Ca ²⁺-activated big-conductance K ⁺ Channels (KCa1.1 channels) activator. NS 11021 at concentrations above 0.3 μM activates KCa1.1 in a concentration-dependent manner by parallelshifting the channel activation curves to more negative potentials .

HY-114920

Piprofurol	Calcium Channel	Cardiovascular Disease
Piprofurol is a calcium channel inhibitor. Piprofurol inhibits the calcium-induced contractions in isolated potassium depolarized preparations of rat aorta in a concentration-dependent manner and relaxes the K ⁺-induced contraction of the dog coronary artery and the rabbit basilar artery. Piprofurol exerts a negative inotropic effect on guinea-pig papillary muscle, with the EC₅₀ of 5 μM .

HY-153542

AP-C6	Others	Others
AP-C6 is a potent inhibitor of guanosine 3′,5′-cyclic monophosphate (cGMP)-dependent protein kinase II (cGKII) with a pIC₅₀ of 6.5. AP-C6 concentration-dependently inhibits human cGKII activity in vitro. AP-C6 potentiate cAMP signaling by PDE inhibition .

Cat. No.	Product Name	Target	Research Area

HY-P1236

Atrial Natriuretic Peptide (ANP) (1-28), rat Atrial natriuretic factor (1-28) (rat)	Endothelin Receptor	Cardiovascular Disease Endocrinology
Atrial Natriuretic Peptide (ANP) (1-28), rat is a major circulating form of ANP in rats, potently inhibits Angiotensin II (Ang II)-stimulated endothelin-1 secretion in a concentration-dependent manner.

HY-P5067

EAK16-II

Peptides Others

EAK16-II is an amphipathic peptide that inhibits the self-sorting of EAKIIH6 in a concentration-dependent manner .

HY-P1236A

Atrial Natriuretic Peptide (ANP) (1-28), rat TFA Atrial natriuretic factor (1-28) (rat) TFA	Endothelin Receptor	Cardiovascular Disease Endocrinology
Atrial Natriuretic Peptide (ANP) (1-28), rat (TFA) is a major circulating form of ANP in rats, potently inhibits Angiotensin II (Ang II)-stimulated endothelin-1 secretion in a concentration-dependent manner.

HY-P3562

PL-3994	Peptides	Others
PL-3994 is a natriuretic peptide receptor-A (NPR-A) agonist that is resistant to neutral endopeptidase and acts as a bronchodilator. PL-3994 produces concentration-dependent relaxation of pre-contracted guinea-pig trachea with an IC₅₀ value of 42.7 nM .

HY-106323

[Leu13]-Motilin KW-5139	Motilin Receptor	Metabolic Disease
[Leu13]-Motilin (KW-5139) is a motilin analogue. [Leu13]-Motilin stimulates gastrointestinal motility in the rabbit. [Leu13]-Motilin causes concentration-dependent contractions of the gastric antrum, duodenum, jejunum, ileum and the descending colon in vitro .

HY-P3678

Neuropeptide Y (18-36) (porcine)	Neuropeptide Y Receptor	Cardiovascular Disease Neurological Disease
Neuropeptide Y (18-36) (porcine) is a competitive neuropeptide Y (NPY) cardiac receptor antagonist. Neuropeptide Y (18-36) (porcine) inhibits the binding of I-NPY to cardiac ventricular membranes in a concentration-dependent manner with an IC₅₀ value of 158 nM and an K_i value of 140 nM. Neuropeptide Y (18-36) (porcine) can be used for the research of congestive heart failure .

HY-P1997

Ferrichrome Iron-free Desferrichrome; DFC; N-Desferriferrichrome	Biochemical Assay Reagents	Others
Ferrichrome is a hydroxamate siderophore produced by various fungi, including U. sphaerogena, that facilitates iron chelation and uptake by these organisms. It can be used as a heterosiderophore by bacteria, including Pseudomonas aeruginosa and Vibrio parahaemolyticus. Ferrichrome (0.8 μM) inhibits concanavalin A-induced proliferation of mouse spleen monocytes and reduces the number of concanavalin A-stimulated CD4+ T cells expressing IL-2 receptor. It also inhibits the heme-catalyzed oxidation of LDL by hydrogen peroxide in a concentration-dependent manner.

HY-P5493

D-Arg-[Hyp3,Thi5,8,D-Phe7]-Bradykinin	Peptides	Others
D-Arg-[Hyp3,Thi5,8,D-Phe7]-Bradykinin is a biological active peptide. (inhibited bradykinin-induced contractions concentration dependently; bradykinin B2 receptor antagonist)

Cat. No.	Product Name	Category	Target	Chemical Structure